Menopause Drops
Generic Name: menopause drops
Brand Names:
Menopause Drops 2044
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS For the temporary relief of hot flashes, sweating, irritability, difficulty sleeping, or fatigue.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age. Not intended for use in infants.
Warnings
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Menopause Drops used for?▼
INDICATIONS For the temporary relief of hot flashes, sweating, irritability, difficulty sleeping, or fatigue.*
Can I take Menopause Drops during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Menopause Drops?▼
WARNINGS In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Ziftomenib
ziftomenib
Menin Inhibitor [EPC]
11 DESCRIPTION KOMZIFTI contains ziftomenib, a menin inhibitor. The chemical name is ( S )-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1 H -indole-2-carbonitrile. The chemical structure is: The molecular formula is C 33 H 42 F 3 N 9 O 2 S 2 and the molecular weight is 717.88 g/mol.
Ibalizumab
ibalizumab
CD4-directed Blocking Antibody [EPC]
11 DESCRIPTION TROGARZO is a CD4-directed post-attachment HIV-1 inhibitor. Ibalizumab-uiyk is a CD4 domain 2-directed humanized monoclonal antibody of immunoglobulin G (IgG) isotype 4 with a molecular weight of approximately 150 kDa. Ibalizumab-uiyk is produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells.
Daytime - Acetaminophen, Dextromethrophan Hbr And Nighttime - Acetaminophen, Dextromethrophan Hbr, Doxylamine Succinate
daytime - acetaminophen, dextromethrophan hbr and nighttime - acetaminophen, dextromethrophan hbr, doxylamine succinate
Purpose Pain reliever/fever reducer Cough suppressant Nasal decongestant
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.